Comparison of three rapid diagnostic tests for bloodstream infections using Benefit-risk Evaluation Framework (BED-FRAME)
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.01096-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Richard D Smith und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Bacteremia, Sepsis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Rapid diagnostic tests (RDTs) for bloodstream infections have the potential to reduce time to appropriate antimicrobial therapy and improve patient outcomes. Previously, an in-house, lipid-based, matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) method, Fast Lipid Analysis Technique (FLAT MS), has shown promise as a rapid pathogen identification method. In this study, FLAT MS for direct from blood culture identification was evaluated and compared to FDA-cleared identification methods using the Benefit-risk Evaluation Framework (BED-FRAME) analysis. FLAT MS was evaluated and compared to Bruker Sepsityper and bioMérieux BioFire FilmArray BCID2 using results from a previous study. For this study, 301 positive blood cultures were collected from the University of Maryland Medical Center. The RDTs were compared by their sensitivities, time-to-results, hands-on time, and BED-FRAME analysis. The overall sensitivity of all platforms compared to culture results from monomicrobial-positive blood cultures was 88.3%. However, the three RDTs differed in their accuracy for identifying Gram-positive bacteria, Gram-negative bacteria, and yeast. Time-to-results for FLAT MS, Sepsityper, and BioFire BCID2 were all approximately one hour. Hands-on times for FLAT MS, Sepsityper, and BioFire BCID2 were 10 (±1.3), 40 (±2.8), and 5 (±0.25) minutes, respectively. BED-FRAME demonstrated that each RDT had utility at different pathogen prevalence and relative importance. BED-FRAME is a useful tool that can used to determine which RDT is best for a healthcare center.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
- Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Biostatistics Center and the Department of Biostatistics and Bioinformatics, The George Washington University, Washington, D.C., USA.
- Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Richard D Smith, Yohei Doi, Robert K Ernst
Förderung
- NIAID NIH HHS
Zitieren
APA
Smith, R. D., Zhan, M., Zhang, S., Leekha, S., Harris, A., Doi, Y., Evans, S., Kristie Johnson, J., & Ernst, R. K. (2024). Comparison of three rapid diagnostic tests for bloodstream infections using Benefit-risk Evaluation Framework (BED-FRAME). Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01096-23
Vancouver
Smith RD, Zhan M, Zhang S, Leekha S, Harris A, Doi Y, et al. Comparison of three rapid diagnostic tests for bloodstream infections using Benefit-risk Evaluation Framework (BED-FRAME). Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.01096-23
BibTeX
@article{Smith2024,
author = {Smith, Richard D and Zhan, Min and Zhang, Shanshan and Leekha, Surbhi and Harris, Anthony and Doi, Yohei and Evans, Scott and Kristie Johnson, J and Ernst, Robert K},
title = {Comparison of three rapid diagnostic tests for bloodstream infections using Benefit-risk Evaluation Framework (BED-FRAME)},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.01096-23}
}
EUVIMED